Suchergebnisse - (Person:"Cinatl, Jindrich")

PubPharm (24)

1

Intact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines

enthalten in: Cells | 2019

von Povey, J. | Saintas, E. | Aderemi, A. | +8

2

The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2018

von Knecht, K. | Buzovetsky, O. | Schneider, C. | +12

3

BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells

enthalten in: Neoplasia (New York, N.Y.) | 2018

von Das, C. | Linder, B. | Bonn, F. | +6

4

Key Players of Cisplatin Resistance : Towards a Systems Pharmacology Approach

enthalten in: International journal of molecular sciences | 2018

von Sarin, N. | Engel, F. | Rothweiler, F. | +5

5

Knowledge-based approach to identify key determinants of cisplatin sensitivity 

enthalten in: International journal of clinical pharmacology and therapeutics | 2017

von Sarin, N. | Engel, F. | Kalayda, G. | +6

6

Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS

enthalten in: PloS one | 2017

von Saintas, E. | Abrahams, L. | Ahmad, G. | +37

7

Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest

enthalten in: PloS one | 2017

von Sarin, N. | Engel, F. | Kalayda, G. | +8

8

Utilising the EGFR interactome to identify mechanisms of drug resistance in non-small cell lung cancer - Proof of concept towards a systems pharmacology approach

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2016

von Saafan, H. | Foerster, S. | Parra-Guillen, Z. | +7

9

ABCB1 as predominant resistance mechanism in cells with acquired SNS-032 resistance

enthalten in: Oncotarget | 2016

von Löschmann, N. | Michaelis, M. | Rothweiler, F. | +4

10

Relevance of subcellular localization of extracellular signal-regulated kinase 1/2 (ERK1/2) for cisplatin resistance

enthalten in: International journal of clinical pharmacology and therapeutics | 2015

von Dilruba, S. | Michaelis, M. | Cinatl, J. | +1